Free shipping on all orders over $ 500

(-)-Huperzine A

Cat. No. M3253
(-)-Huperzine A Structure
Synonym:

Huperzine A

Size Price Availability Quantity
Free Sample (0.5-1 mg)  USD 0 In stock
5mg USD 34  USD34 In stock
10mg USD 48  USD48 In stock
50mg USD 166  USD166 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

(-)-Huperzine A is an Acetylcholinesterase inhibitor and NMDA receptor antagonist with an IC50 of 126 μM for NMDA-induced current. Huperzine A, is a naturally occurring sesquiterpene alkaloid compound found in the plant firmoss Huperzia serrata. The IC (50) values of huperzine A were neither altered by changing the concentrations of glycine (2-0.2 μM) and pH (7.4-6.7) in the external solution, nor by addition of Zn (2+) (5 μM) and dithiothreitol (5 mM) to the external solution.

Protocol (for reference only)
Cell Experiment
Cell lines
Preparation method
Concentrations
Incubation time
Animal Experiment
Animal models Male Sprague-Dawley rats
Formulation Saline
Dosages 0.1 mg/kg
Administration Orally
Chemical Information
Molecular Weight 242.32
Formula C15H18N2O
CAS Number 102518-79-6
Solubility (25°C) DMSO 10 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Mara Jess Friedli, et al. Huperzine A and Its Neuroprotective Molecular Signaling in Alzheimer's Disease

[2] Nafiseh Ghassab-Abdollahi, et al. The effects of Huperzine A on dementia and mild cognitive impairment: An overview of systematic reviews

[3] Xiao Sang, et al. Research on endophytic fungi for producing huperzine A on a large-scale

[4] Guoyan Yang, et al. Huperzine A for Alzheimer's disease: a systematic review and meta-analysis of randomized clinical trials

[5] No authors listed. Drugs R D. Huperzine A

Related AChR/AChE Products
Tacrine

Tacrine is a potent acetylcholinesterse (AChE) inhibitor (IC50=109 nM), also acting as a CYP1A2 substrate agent.

THRX-160209

THRX-160209 is a potent antagonist at the M(2) muscarinic acetylcholine (ACh) receptor subtype that was designed using a multivalent strategy, simultaneously targeting the orthosteric site and a nearby site known to bind allosteric ligands.

Catestatin

Catestatin is a 21-amino acid residue, cationic and hydrophobic peptide.

α-Conotoxin MII

α-Conotoxin MII (α-CTxMII), a 16-amino acid peptide from the venom of the marine snail Conus magus, potently blocks nicotinic acetylcholine receptors (nAChRs) composed of α3β2 subunits, with an IC50 of 0.5 nM.

COG 133 TFA

COG 133 TFA is a fragment of Apolipoprotein E (APOE) peptide.

  Catalog
Abmole Inhibitor Catalog




Keywords: (-)-Huperzine A, Huperzine A supplier, AChR/AChE, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.